Alvogen has announced the acquisition of specialty generic pharmaceutical company County Line for an undisclosed sum. Alvogen is majority owned by Pamplona Capital Management.
Founded in 2007, County Line focuses on under-appreciated generic assets and specialty generic products.
It has a balanced portfolio that spans multiple dosage forms including oral solutions, creams, ointments, gels and orally disintegrating tablets with 12 marketed products in the US and leading positions across all its commercial product areas.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze